Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 124 entries
Sorted by: Best Match Show Resources per page
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.

OncoTargets and therapy

Creelan BC, Gabrilovich DI, Gray JE, Williams CC, Tanvetyanon T, Haura EB, Weber JS, Gibney GT, Markowitz J, Proksch JW, Reisman SA, McKee MD, Chin MP, Meyer CJ, Antonia SJ.
PMID: 28919776
Onco Targets Ther. 2017 Aug 29;10:4239-4250. doi: 10.2147/OTT.S136992. eCollection 2017.

BACKGROUND: Omaveloxolone is a semisynthetic oleanane triterpenoid that potently activates Nrf2 with subsequent antioxidant function. We conducted a first-in-human Phase I clinical trial (NCT02029729) with the primary objectives to determine the appropriate dose for Phase II studies, characterize pharmacokinetic...

Cite
Creelan BC, Gabrilovich DI, Gray JE, et al. Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors. Onco Targets Ther. 2017;10:4239-4250doi: 10.2147/OTT.S136992.
Creelan, B. C., Gabrilovich, D. I., Gray, J. E., Williams, C. C., Tanvetyanon, T., Haura, E. B., Weber, J. S., Gibney, G. T., Markowitz, J., Proksch, J. W., Reisman, S. A., McKee, M. D., Chin, M. P., Meyer, C. J., & Antonia, S. J. (2017). Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors. OncoTargets and therapy, 104239-4250. https://doi.org/10.2147/OTT.S136992
Creelan, Ben C, et al. "Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors." OncoTargets and therapy vol. 10 (2017): 4239-4250. doi: https://doi.org/10.2147/OTT.S136992
Creelan BC, Gabrilovich DI, Gray JE, Williams CC, Tanvetyanon T, Haura EB, Weber JS, Gibney GT, Markowitz J, Proksch JW, Reisman SA, McKee MD, Chin MP, Meyer CJ, Antonia SJ. Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors. Onco Targets Ther. 2017 Aug 29;10:4239-4250. doi: 10.2147/OTT.S136992. eCollection 2017. PMID: 28919776; PMCID: PMC5587199.
Copy Download .nbib Format: NLM
Do improvements in balance relate to improvements in long-distance walking function after stroke?.

Stroke research and treatment

Awad LN, Reisman DS, Binder-Macleod SA.
PMID: 25120939
Stroke Res Treat. 2014;2014:646230. doi: 10.1155/2014/646230. Epub 2014 Jul 10.

Stroke survivors identify a reduced capacity to walk farther distances as a factor limiting their engagement at home and in community. Previous observational studies have shown that measures of balance ability and balance self-efficacy are strong predictors of long-distance...

Cite
Awad LN, Reisman DS, Binder-Macleod SA. Do improvements in balance relate to improvements in long-distance walking function after stroke?. Stroke Res Treat. 2014;2014:646230doi: 10.1155/2014/646230.
Awad, L. N., Reisman, D. S., & Binder-Macleod, S. A. (2014). Do improvements in balance relate to improvements in long-distance walking function after stroke?. Stroke research and treatment, 2014646230. https://doi.org/10.1155/2014/646230
Awad, Louis N, et al. "Do improvements in balance relate to improvements in long-distance walking function after stroke?." Stroke research and treatment vol. 2014 (2014): 646230. doi: https://doi.org/10.1155/2014/646230
Awad LN, Reisman DS, Binder-Macleod SA. Do improvements in balance relate to improvements in long-distance walking function after stroke?. Stroke Res Treat. 2014;2014:646230. doi: 10.1155/2014/646230. Epub 2014 Jul 10. PMID: 25120939; PMCID: PMC4121191.
Copy Download .nbib Format: NLM
Primary Gastro Intestinal Lymphoma Presenting as Perforation Peritonitis.

Journal of clinical and diagnostic research : JCDR

Rehaman SA, Ramachandra CS, Jackaya RP.
PMID: 27134938
J Clin Diagn Res. 2016 Mar;10(3):PD22-4. doi: 10.7860/JCDR/2016/15462.7483. Epub 2016 Mar 01.

Primary gastrointestinal lymphoma is very rare compared to gastrointestinal tract lymphoma arising Secondary to Primary nodal disease. Extra nodal lymphoma can involve any part of the gastrointestinal tract, most commonly being the stomach followed by small intestine and ileocecal...

Cite
Rehaman SA, Ramachandra CS, Jackaya RP. Primary Gastro Intestinal Lymphoma Presenting as Perforation Peritonitis. J Clin Diagn Res. 2016;10(3):PD22-4doi: 10.7860/JCDR/2016/15462.7483.
Rehaman, S. A., Ramachandra, C. S., & Jackaya, R. P. (2016). Primary Gastro Intestinal Lymphoma Presenting as Perforation Peritonitis. Journal of clinical and diagnostic research : JCDR, 10(3), PD22-4. https://doi.org/10.7860/JCDR/2016/15462.7483
Rehaman, Suhaib Abdul, et al. "Primary Gastro Intestinal Lymphoma Presenting as Perforation Peritonitis." Journal of clinical and diagnostic research : JCDR vol. 10,3 (2016): PD22-4. doi: https://doi.org/10.7860/JCDR/2016/15462.7483
Rehaman SA, Ramachandra CS, Jackaya RP. Primary Gastro Intestinal Lymphoma Presenting as Perforation Peritonitis. J Clin Diagn Res. 2016 Mar;10(3):PD22-4. doi: 10.7860/JCDR/2016/15462.7483. Epub 2016 Mar 01. PMID: 27134938; PMCID: PMC4843323.
Copy Download .nbib Format: NLM
Chemical Synthesis of (+)-Ryanodine and (+)-20-Deoxyspiganthine.

ACS central science

Xu C, Han A, Virgil SC, Reisman SE.
PMID: 28470044
ACS Cent Sci. 2017 Apr 26;3(4):278-282. doi: 10.1021/acscentsci.6b00361. Epub 2017 Mar 09.

(+)-Ryanodine is a natural product modulator of ryanodine receptors, important intracellular calcium ion channels that play a critical role in signal transduction leading to muscle movement and synaptic transmission. Chemical derivatization of (+)-ryanodine has demonstrated that certain peripheral structural...

Cite
Xu C, Han A, Virgil SC, et al. Chemical Synthesis of (+)-Ryanodine and (+)-20-Deoxyspiganthine. ACS Cent Sci. 2017;3(4):278-282doi: 10.1021/acscentsci.6b00361.
Xu, C., Han, A., Virgil, S. C., & Reisman, S. E. (2017). Chemical Synthesis of (+)-Ryanodine and (+)-20-Deoxyspiganthine. ACS central science, 3(4), 278-282. https://doi.org/10.1021/acscentsci.6b00361
Xu, Chen, et al. "Chemical Synthesis of (+)-Ryanodine and (+)-20-Deoxyspiganthine." ACS central science vol. 3,4 (2017): 278-282. doi: https://doi.org/10.1021/acscentsci.6b00361
Xu C, Han A, Virgil SC, Reisman SE. Chemical Synthesis of (+)-Ryanodine and (+)-20-Deoxyspiganthine. ACS Cent Sci. 2017 Apr 26;3(4):278-282. doi: 10.1021/acscentsci.6b00361. Epub 2017 Mar 09. PMID: 28470044; PMCID: PMC5409222.
Copy Download .nbib Format: NLM
MRI.

Annals of internal medicine

Reisman AB.
PMID: 10929165
Ann Intern Med. 2000 Aug 15;133(4):262. doi: 10.7326/0003-4819-133-4-200008150-00008.

No abstract available.

Cite
Reisman AB. MRI. Ann Intern Med. 2000;133(4):262doi: 10.7326/0003-4819-133-4-200008150-00008.
Reisman, A. B. (2000). MRI. Annals of internal medicine, 133(4), 262. https://doi.org/10.7326/0003-4819-133-4-200008150-00008
Reisman. "MRI." Annals of internal medicine vol. 133,4 (2000): 262. doi: https://doi.org/10.7326/0003-4819-133-4-200008150-00008
Reisman AB. MRI. Ann Intern Med. 2000 Aug 15;133(4):262. doi: 10.7326/0003-4819-133-4-200008150-00008. PMID: 10929165.
Copy Download .nbib Format: NLM
Responses from US readers to the Webcast video editorial entitled "American Healthcare is the best in the world if...".

MedGenMed : Medscape general medicine

Bansal N, Greif EE, Bosch R, Holland JD, Dixon T, Cohen SD, Hernandez M, Reisman EM, Burgio D, Peckham C, Hennenfent B, Garcia MA, Govatos J, Morton ML.
PMID: 15520650
MedGenMed. 2004 Sep 28;6(3):26.

No abstract available.

Cite
Bansal N, Greif EE, Bosch R, et al. Responses from US readers to the Webcast video editorial entitled "American Healthcare is the best in the world if...". MedGenMed. 2004;6(3):26
Bansal, N., Greif, E. E., Bosch, R., Holland, J. D., Dixon, T., Cohen, S. D., Hernandez, M., Reisman, E. M., Burgio, D., Peckham, C., Hennenfent, B., Garcia, M. A., Govatos, J., & Morton, M. L. (2004). Responses from US readers to the Webcast video editorial entitled "American Healthcare is the best in the world if...". MedGenMed : Medscape general medicine, 6(3), 26.
Bansal, Narendra, et al. "Responses from US readers to the Webcast video editorial entitled "American Healthcare is the best in the world if..."." MedGenMed : Medscape general medicine vol. 6,3 (2004): 26.
Bansal N, Greif EE, Bosch R, Holland JD, Dixon T, Cohen SD, Hernandez M, Reisman EM, Burgio D, Peckham C, Hennenfent B, Garcia MA, Govatos J, Morton ML. Responses from US readers to the Webcast video editorial entitled "American Healthcare is the best in the world if...". MedGenMed. 2004 Sep 28;6(3):26. PMID: 15520650; PMCID: PMC1435641.
Copy Download .nbib Format: NLM
Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patients.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Merrill JT, Diakolios C, Goodman S, Dinu A, Shen C, Lahita RG, Cronstein BN, Mitnick H, Bauer B, Paget S, Greisman S.
PMID: 19078220
J Clin Rheumatol. 1997 Dec;3(6):328-33.

Methotrexate is one of the most effective and widely used medications in the treatment of rheumatoid arthritis. One poorly understood side effect of methotrexate is increased rheumatoid nodule formation, a phenomenon which has been reported to occur in some...

Cite
Merrill JT, Diakolios C, Goodman S, et al. Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patients. J Clin Rheumatol. 1997;3(6):328-33
Merrill, J. T., Diakolios, C., Goodman, S., Dinu, A., Shen, C., Lahita, R. G., Cronstein, B. N., Mitnick, H., Bauer, B., Paget, S., & Greisman, S. (1997). Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patients. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 3(6), 328-33.
Merrill, J T, et al. "Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patients." Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. 3,6 (1997): 328-33.
Merrill JT, Diakolios C, Goodman S, Dinu A, Shen C, Lahita RG, Cronstein BN, Mitnick H, Bauer B, Paget S, Greisman S. Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patients. J Clin Rheumatol. 1997 Dec;3(6):328-33. PMID: 19078220.
Copy Download .nbib Format: NLM
Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy.

Substance abuse : research and treatment

Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR.
PMID: 24357929
Subst Abuse. 2009 May 01;3:41-51. doi: 10.4137/sart.s2345. eCollection 2009.

CONTEXT: The dramatic rise in the use of prescription opioids to treat non-cancer pain has been paralleled by increasing prescription opioid abuse. However, detailed analyses of these trends and programs to address them are lacking.OBJECTIVE: To study the association...

Cite
Reisman RM, Shenoy PJ, Atherly AJ, et al. Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Subst Abuse. 2009;3:41-51doi: 10.4137/sart.s2345.
Reisman, R. M., Shenoy, P. J., Atherly, A. J., & Flowers, C. R. (2009). Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Substance abuse : research and treatment, 341-51. https://doi.org/10.4137/sart.s2345
Reisman, Richard M, et al. "Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy." Substance abuse : research and treatment vol. 3 (2009): 41-51. doi: https://doi.org/10.4137/sart.s2345
Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR. Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Subst Abuse. 2009 May 01;3:41-51. doi: 10.4137/sart.s2345. eCollection 2009. PMID: 24357929; PMCID: PMC3865068.
Copy Download .nbib Format: NLM
Radical Deoxychlorination of Cesium Oxalates for the Synthesis of Alkyl Chlorides.

Organic letters

Su JY, Grünenfelder DC, Takeuchi K, Reisman SE.
PMID: 30062894
Org Lett. 2018 Aug 17;20(16):4912-4916. doi: 10.1021/acs.orglett.8b02045. Epub 2018 Jul 31.

A radical deoxychlorination of cesium oxalates has been developed for the preparation of hindered secondary and tertiary alkyl chlorides. The reaction tolerates a number of functional groups, including ketones, alcohols, and amides, and provides complementary reactivity to standard deoxychlorination...

Cite
Su JY, Grünenfelder DC, Takeuchi K, et al. Radical Deoxychlorination of Cesium Oxalates for the Synthesis of Alkyl Chlorides. Org Lett. 2018;20(16):4912-4916doi: 10.1021/acs.orglett.8b02045.
Su, J. Y., Grünenfelder, D. C., Takeuchi, K., & Reisman, S. E. (2018). Radical Deoxychlorination of Cesium Oxalates for the Synthesis of Alkyl Chlorides. Organic letters, 20(16), 4912-4916. https://doi.org/10.1021/acs.orglett.8b02045
Su, Justin Y, et al. "Radical Deoxychlorination of Cesium Oxalates for the Synthesis of Alkyl Chlorides." Organic letters vol. 20,16 (2018): 4912-4916. doi: https://doi.org/10.1021/acs.orglett.8b02045
Su JY, Grünenfelder DC, Takeuchi K, Reisman SE. Radical Deoxychlorination of Cesium Oxalates for the Synthesis of Alkyl Chlorides. Org Lett. 2018 Aug 17;20(16):4912-4916. doi: 10.1021/acs.orglett.8b02045. Epub 2018 Jul 31. PMID: 30062894.
Copy Download .nbib Format: NLM
Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development.

Oncoscience

Marquez-Vilendrer SB, Rai SK, Gramling SJ, Lu L, Reisman DN.
PMID: 28105457
Oncoscience. 2016 Nov 17;3(11):322-336. doi: 10.18632/oncoscience.323. eCollection 2016.

Inactivation of

Cite
Marquez-Vilendrer SB, Rai SK, Gramling SJ, et al. Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development. Oncoscience. 2016;3(11):322-336doi: 10.18632/oncoscience.323.
Marquez-Vilendrer, S. B., Rai, S. K., Gramling, S. J., Lu, L., & Reisman, D. N. (2016). Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development. Oncoscience, 3(11), 322-336. https://doi.org/10.18632/oncoscience.323
Marquez-Vilendrer, Stefanie B, et al. "Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development." Oncoscience vol. 3,11 (2016): 322-336. doi: https://doi.org/10.18632/oncoscience.323
Marquez-Vilendrer SB, Rai SK, Gramling SJ, Lu L, Reisman DN. Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development. Oncoscience. 2016 Nov 17;3(11):322-336. doi: 10.18632/oncoscience.323. eCollection 2016. PMID: 28105457; PMCID: PMC5235921.
Copy Download .nbib Format: NLM
Identifying candidates for targeted gait rehabilitation after stroke: better prediction through biomechanics-informed characterization.

Journal of neuroengineering and rehabilitation

Awad LN, Reisman DS, Pohlig RT, Binder-Macleod SA.
PMID: 27663199
J Neuroeng Rehabil. 2016 Sep 23;13(1):84. doi: 10.1186/s12984-016-0188-8.

BACKGROUND: Walking speed has been used to predict the efficacy of gait training; however, poststroke motor impairments are heterogeneous and different biomechanical strategies may underlie the same walking speed. Identifying which individuals will respond best to a particular gait...

Cite
Awad LN, Reisman DS, Pohlig RT, et al. Identifying candidates for targeted gait rehabilitation after stroke: better prediction through biomechanics-informed characterization. J Neuroeng Rehabil. 2016;13(1):84doi: 10.1186/s12984-016-0188-8.
Awad, L. N., Reisman, D. S., Pohlig, R. T., & Binder-Macleod, S. A. (2016). Identifying candidates for targeted gait rehabilitation after stroke: better prediction through biomechanics-informed characterization. Journal of neuroengineering and rehabilitation, 13(1), 84. https://doi.org/10.1186/s12984-016-0188-8
Awad, Louis N, et al. "Identifying candidates for targeted gait rehabilitation after stroke: better prediction through biomechanics-informed characterization." Journal of neuroengineering and rehabilitation vol. 13,1 (2016): 84. doi: https://doi.org/10.1186/s12984-016-0188-8
Awad LN, Reisman DS, Pohlig RT, Binder-Macleod SA. Identifying candidates for targeted gait rehabilitation after stroke: better prediction through biomechanics-informed characterization. J Neuroeng Rehabil. 2016 Sep 23;13(1):84. doi: 10.1186/s12984-016-0188-8. PMID: 27663199; PMCID: PMC5035477.
Copy Download .nbib Format: NLM
The development of a reference database with the Topcon 3D OCT-1 Maestro.

Clinical ophthalmology (Auckland, N.Z.)

Chaglasian M, Fingeret M, Davey PG, Huang WC, Leung D, Ng E, Reisman CA.
PMID: 29765199
Clin Ophthalmol. 2018 May 07;12:849-857. doi: 10.2147/OPTH.S155229. eCollection 2018.

IMPORTANCE: The paper presents the range for measurements taken with a new spectral domain optical coherence tomography (OCT) device to establish a reference database for discrimination purposes.OBJECTIVE: To report the range of thickness values for the new Topcon Maestro...

Cite
Chaglasian M, Fingeret M, Davey PG, et al. The development of a reference database with the Topcon 3D OCT-1 Maestro. Clin Ophthalmol. 2018;12:849-857doi: 10.2147/OPTH.S155229.
Chaglasian, M., Fingeret, M., Davey, P. G., Huang, W. C., Leung, D., Ng, E., & Reisman, C. A. (2018). The development of a reference database with the Topcon 3D OCT-1 Maestro. Clinical ophthalmology (Auckland, N.Z.), 12849-857. https://doi.org/10.2147/OPTH.S155229
Chaglasian, Michael, et al. "The development of a reference database with the Topcon 3D OCT-1 Maestro." Clinical ophthalmology (Auckland, N.Z.) vol. 12 (2018): 849-857. doi: https://doi.org/10.2147/OPTH.S155229
Chaglasian M, Fingeret M, Davey PG, Huang WC, Leung D, Ng E, Reisman CA. The development of a reference database with the Topcon 3D OCT-1 Maestro. Clin Ophthalmol. 2018 May 07;12:849-857. doi: 10.2147/OPTH.S155229. eCollection 2018. PMID: 29765199; PMCID: PMC5944450.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 124 entries